Opioids Market Overview to 2023 - Opioids in Emerging Markets: Radiant Insights

Summary 

The report provides analysis of new developments that will have a strong bearing on the use of opioids in pain management in emerging countries (Argentina, Brazil, China, India, Mexico, Russia and South Africa). Access to opioids is restricted under strict drug control policies and regulations overseeing controlled medicines due to their high abuse potential. Emphasis on restricting access to controlled drugs is much higher in emerging markets than in developed nations, resulting in a level of consumption that is too low to meet pain-control requirements even in cases of terminal illness. There is a high level of unmet need for pain control in both cancer and HIV/AIDS, and serious concerns have been raised regarding inadequate pain management in the emerging markets.

To Download Sample Copy of This Report, Visit here: http://www.radiantinsights.com/research/opioids-market-overview-to-2023-opioids-in-emerging-markets  

However, this is expected to change in the near future as regulatory authorities attempt to remedy the situation. Indeed, several new developments promise a better outlook for future access. Although India currently has a minor share of the market, it is expected to post a high growth rate (21.3% by 2023) due to improved access to opioid analgesics. Similarly, consumption in Brazil and Argentina is also expected to increase due to recent changes to their palliative care policies. Although the opioids market in emerging countries is small, it is expected to grow at a faster pace in forecast period than in some developed countries. 

Scope

 "Opioids in Emerging Markets covers" the major emerging markets of Argentina, Brazil, China, India, Mexico, Russia, and South Africa, and includes - 

- Discussion of the key challenges that restrict opioid use in pain management

- Analysis of the inadequate use of opioids in pain control and the associated unmet need

- Discussion of the key changes in the regulatory and legal landscape that affect opioids, prescription barriers, palliative care, and harm-reduction activities

- Analysis of recent developments in emerging markets and their expected impact on opioid accessibility and usage

- Country snapshots, which include key regulations, consumption, market revenues and forecasts, and key drivers and barriers in India, Brazil and South Africa

- Snapshot of consumption trends along with market revenues and forecasts in Argentina and China

Key Reasons to Purchase 

- Understand the key constraints in emerging markets that limit the use of opioids in pain management

- Understand recent changes in the regulatory environment and gauge their impact on opioid usage

- Gain perspective on the unmet need in the opioids market

- Understand the market size and growth potential in emerging markets and identify high-potential countries for opioid products

To Read other reports of this category, click here: http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare   

Table of Contents

Executive Summary

Opioids in pain management 

Opioids in emerging markets: an overview

Low utilization of opioids

Changing regulatory landscape 

Key challenges and barriers in emerging markets

Factors affecting opioid usage

Highly restricted environment

Criminalization of drug use

Lack of palliative care 

Lack of harm-reduction strategies

Opioid consumption in emerging markets

Country snapshots (Brazil, India and South Africa)

Regulatory landscape

Consumption trends

Volume and revenue by molecule

Barriers and activities to rationalize usage

Appendix

Abbreviations/acronyms 

References